Targeting the ERK pathway for the treatment of Cushing's disease
Dongyun Zhang(New York University), Anthony P. Heaney(Cedars-Sinai Medical Center)
Cited by 25
Related Papers
PPAR-γ receptor ligands: novel therapy for pituitary adenomas
|Journal of Clinical Investigation|2003|164
JNK1 Mediates Degradation HIF-1α by a VHL-Independent Mechanism that Involves the Chaperones Hsp90/Hsp70
|Cancer Research|2010|99
The Requirement of c-Jun N-terminal Kinase 2 in Regulation of Hypoxia-inducing Factor-1α mRNA Stability
|Journal of Biological Chemistry|2012|27